Revenue from Contract with Customer, Excluding Assessed Tax of CRESCENT BIOPHARMA, INC. from 31 Dec 2024 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
CRESCENT BIOPHARMA, INC. annual and quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Dec 2024 to 31 Dec 2025.
  • CRESCENT BIOPHARMA, INC. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Dec 2024 was $0.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)

CRESCENT BIOPHARMA, INC. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $10,844,000 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY

CRESCENT BIOPHARMA, INC. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $0 20 Sep 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.